|
End-of-day quote
Nasdaq
2026-08-14
|
5-day change | 1st Jan Change | ||
| 4.055 USD | -0.86% |
|
+6.43% | -20.96% |
| 07-30 | Alvotech Announces Successful Closure Of U.S Food and Drug Administration Inspection Of Manufacturing Facility | CI |
| 07-29 | Alvotech Shares Rise After Wrapping FDA Facility Inspection | DJ |
Company Valuation: Alvotech
Data adjusted to current consolidation scope
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|---|
| Market Cap 1 | 308.8 | 2,486 | 3,048 | 3,991 | 1,606 | 1,447 | - | - |
| Change | - | 705.34% | 22.59% | 30.92% | -59.76% | -9.87% | - | - |
| Enterprise Value (EV) 1 | 308.8 | 3,165 | 3,959 | 5,330 | 2,883 | 2,531 | 2,503 | 2,392 |
| Change | - | 925.01% | 25.11% | 34.63% | -45.92% | -12.21% | -1.08% | -4.45% |
| P/E | -0.8x | -3.85x | -4.72x | -15.2x | 9.5x | 14.6x | 8.46x | 5.79x |
| PBR | - | -4.41x | -2.8x | -8.59x | -5.22x | -6.37x | -13.4x | 11.8x |
| PEG | - | 0x | 0.72x | 0.2x | -0x | -0.3x | 0.1x | 0.1x |
| Capitalization / Revenue | 8.4x | 29.9x | 32.6x | 8.11x | 2.73x | 2.21x | 1.86x | 1.57x |
| EV / Revenue | 8.4x | 38.1x | 42.4x | 10.8x | 4.9x | 3.86x | 3.21x | 2.6x |
| EV / EBITDA | - | -9.71x | -12x | 52.8x | 24.8x | 13.4x | 9.51x | 6.73x |
| EV / EBIT | - | -9.13x | -11.2x | 76.5x | 36.9x | 16.9x | 11.4x | 7.7x |
| EV / FCF | - | -9.04x | -11.5x | -18.3x | -18.7x | -28.1x | 179x | 39.2x |
| FCF Yield | - | -11.1% | -8.72% | -5.45% | -5.36% | -3.56% | 0.56% | 2.55% |
| Dividend per Share 2 | - | - | - | - | - | - | - | - |
| Rate of return | - | - | - | - | - | - | - | - |
| EPS 2 | -12.29 | -2.6 | -2.43 | -0.87 | 0.54 | 0.2656 | 0.4584 | 0.6696 |
| Distribution rate | - | - | - | - | - | - | - | - |
| Net sales 1 | 36.77 | 83.03 | 93.38 | 492 | 588.9 | 655.8 | 779 | 920.9 |
| EBITDA 1 | - | -326 | -330.6 | 100.9 | 116.1 | 188.6 | 263.2 | 355.3 |
| EBIT 1 | - | -346.4 | -354.9 | 69.64 | 78.21 | 149.3 | 219.8 | 310.8 |
| Net income 1 | - | -513.6 | -551.7 | -231.9 | 157.9 | 91.8 | 151.4 | 209.2 |
| Net Debt 1 | - | 678.2 | 911 | 1,340 | 1,277 | 1,083 | 1,056 | 944.8 |
| Reference price 2 | 9.880 | 10.000 | 11.480 | 13.230 | 5.130 | 3.880 | 3.880 | 3.880 |
| Nbr of stocks (in thousands) | 31,250 | 248,650 | 265,530 | 301,640 | 313,019 | 356,912 | - | - |
| Announcement Date | 5/10/22 | 3/1/23 | 3/20/24 | 3/26/25 | 3/18/26 | - | - | - |
1USD in Million2USD
Estimates
P/E, Detailed evolution
| P/E (N) | EV / Sales (N) | EV / EBITDA (N) | Dividend Yield (N) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | 15.27x | 3.86x | 13.42x | -.--% | 1.45B | |
| 33.04x | 5.91x | 17.56x | 0.97% | 48.42B | |
| -21.14x | 288.75x | -21.43x | -.--% | 43.66B | |
| 45.52x | 5.25x | 28.69x | -.--% | 39.51B | |
| 30.48x | 3.03x | 13.08x | -.--% | 38.95B | |
| 30.58x | 8.82x | 22.17x | 0.38% | 32.61B | |
| 32.9x | 5.38x | 24.45x | -.--% | 16.15B | |
| 23.48x | 2.05x | 8.89x | 1.15% | 14.16B | |
| 74.93x | 3.96x | 15.35x | -.--% | 13.37B | |
| Average | 29.45x | 36.33x | 13.57x | 0.28% | 27.59B | |
| Weighted average by Cap. | 26.37x | 55.10x | 12.19x | 0.3% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
Year-on-year evolution of the Yield
- Stock Market
- Stocks
- ALVO Stock
- Valuation Alvotech
Select your edition
All financial news and data tailored to specific country editions
